Six-Minute Walk Distance in Patients With Severe End-Stage COPD ASSOCIATION WITH SURVIVAL AFTER INPATIENT PULMONARY REHABILITATION

被引:30
作者
Enfield, Kyle
Gammon, Sally [4 ]
Floyd, Jennifer [4 ]
Falt, Cassandra [4 ]
Patrie, James [3 ]
Platts-Mills, Thomas A. [2 ]
Truwit, Jonathon D.
Shim, Y. Michael [1 ]
机构
[1] Univ Virginia, Div Pulm & Crit Care Med, Dept Med, Sch Med, Charlottesville, VA 22908 USA
[2] Univ Virginia, Div Allergy & Immunol, Sch Med, Charlottesville, VA 22908 USA
[3] Univ Virginia, Dept Publ Hlth Sci, Charlottesville, VA 22908 USA
[4] HealthS Rehabil Hosp Virginia, Richmond, VA USA
关键词
COPD; inpatient pulmonary rehabilitation; mortality; 6-minute walk test; PERIPHERAL MUSCLE WEAKNESS; OBSTRUCTIVE LUNG-DISEASE; RANDOMIZED-TRIAL; UNITED-STATES; BODE INDEX; EXERCISE; LIMITATION; MORTALITY; ENDURANCE; DYSPNEA;
D O I
10.1097/HCR.0b013e3181c565e4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PURPOSE: To evaluate the relationship between the 6-minute walk distance (6MWD) and survival in a cohort of patients with severe end-stage chronic obstructive pulmonary disease (COPD) who received inpatient pulmonary rehabilitation (IPR) from 1995 to 2007. METHODS: We retrospectively analyzed 815 patients with severe end-stage COPD who received IPR. 6MWDs before and after IPR (pre-6MWD, post-6MWD) were compared to assess whether 6MWD was significantly changed after IPR. The Kaplan-Meier survival curves were constructed to show the relationship between survival and 6MWD. The age- and or comorbidities-adjusted Cox proportional hazard model was applied to assess association between the survival and the pre-6MWD, post-6MWD, or difference in 6MWD from the pre-6MWD to post-6MWD (Delta 6MWD). RESULTS: Baseline demographics demonstrated a median age 74.0 years, mostly women (60.1%), and white (89.9%) patients with significant comorbid diseases who were most recently hospitalized in acute care facilities (95.1%). IPR significantly increased the 6MWD (mean distance change: 86.4 m; 95% confidence interval [CI], 81.5-91.3 m). Pre-6MWD was not significantly associated with survival. However, post-6MWD was significantly associated with age- and comorbidity-adjusted survival (post-6MWD hazard ratio = 1.336; 95% CI, 1.232-1.449 [post-6MWD x m relative to post-6MWD 2 x m]), and Delta 6MWD was also significantly associated with age-, comorbidities-, and pre-6MWD-adjusted survival (Delta 6MWD hazard ratio = 1.337; 95% CI, 1.227-1.457 [Delta 6MWD x m relative to Delta 6MWD 2 x m]). CONCLUSIONS: In patients with severe end-stage COPD, IPR significantly improved 6MWD, and the post-6MWD and Delta 6MWD were positively associated with the length of survival.
引用
收藏
页码:195 / 202
页数:8
相关论文
共 29 条
[1]   Peripheral muscle weakness in patients with chronic obstructive pulmonary-disease [J].
Bernard, S ;
LeBlanc, P ;
Whittom, F ;
Carrier, G ;
Jobin, J ;
Belleau, R ;
Maltais, F .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1998, 158 (02) :629-634
[2]   Predictive significance of the six-minute walk distance for long-term survival in chronic hypercapnic respiratory failure [J].
Budweiser, Stephan ;
Heidtkamp, Felix ;
Joerres, Rudolf A. ;
Heinemann, Frank ;
Arzt, Michael ;
Schroll, Stephan ;
Schmidbauer, Kathrin ;
Hitzl, Andre P. ;
Pfeifer, Michael .
RESPIRATION, 2008, 75 (04) :418-426
[3]   Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper [J].
Celli, BR ;
MacNee, W ;
Agusti, A ;
Anzueto, A ;
Berg, B ;
Buist, AS ;
Calverley, PMA ;
Chavannes, N ;
Dillard, T ;
Fahy, B ;
Fein, A ;
Heffner, J ;
Lareau, S ;
Meek, P ;
Martinez, F ;
McNicholas, W ;
Muris, J ;
Austegard, E ;
Pauwels, R ;
Rennard, S ;
Rossi, A ;
Siafakas, N ;
Tiep, B ;
Vestbo, J ;
Wouters, E ;
ZuWallack, R .
EUROPEAN RESPIRATORY JOURNAL, 2004, 23 (06) :932-946
[4]   The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease [J].
Celli, BR ;
Cote, CG ;
Marin, JM ;
Casanova, C ;
de Oca, MM ;
Mendez, RA ;
Pinto Plata, V ;
Cabral, HJ .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (10) :1005-1012
[5]  
Clini E M, 2005, Chron Respir Dis, V2, P43
[6]   Outcomes following acute exacerbation of severe chronic obstructive lung disease [J].
Connors, AF ;
Dawson, NV ;
Thomas, C ;
Harrell, FE ;
Desbiens, N ;
Fulkerson, WJ ;
Kussin, P ;
Bellamy, P ;
Goldman, L ;
Knaus, WA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1996, 154 (04) :959-967
[7]   The modified BODE index: validation with mortality in COPD [J].
Cote, C. G. ;
Pinto-Plata, V. M. ;
Marin, J. M. ;
Nekach, H. ;
Dordelly, L. J. ;
Celli, B. R. .
EUROPEAN RESPIRATORY JOURNAL, 2008, 32 (05) :1269-1274
[8]   Pulmonary rehabilitation and the BODE index in COPD [J].
Cote, CG ;
Celli, BR .
EUROPEAN RESPIRATORY JOURNAL, 2005, 26 (04) :630-636
[9]   The 6-min walk distance, peak oxygen uptake, and mortality in COPD [J].
Cote, Claudia G. ;
Pinto-Plata, Victor ;
Kasprzyk, Kyra ;
Dordelly, Luis J. ;
Celli, Bartolome R. .
CHEST, 2007, 132 (06) :1778-1785
[10]   ATS statement: Guidelines for the six-minute walk test [J].
Crapo, RO ;
Casaburi, R ;
Coates, AL ;
Enright, PL ;
MacIntyre, NR ;
McKay, RT ;
Johnson, D ;
Wanger, JS ;
Zeballos, RJ ;
Bittner, V ;
Mottram, C .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2002, 166 (01) :111-117